TY - JOUR
T1 - Assessment of care of patients with asthma in a family practice training program
AU - Craig, Timothy J.
PY - 1996
Y1 - 1996
N2 - To determine if primary care physicians have been adhering to guidelines set forth by the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report Guidelines for the Diagnosis and Management of Asthma, the author gauged the use of peak flow meters in a hospital family training program. Specifically investigated were the physicians' response to results from the peak flow meters and their prescribing practices regarding the beclomethasone dipropionate metered-dose inhaler. Overall, the use of peak flow meters among the 20 patients included in this study averaged 70%, up from 10% in earlier studies. Similarly, 45% of these patients received prescriptions for beclomethasone metered-dose inhalers with spacer devices. Although these results appear to indicate that physicians are following the aforementioned guidelines, the author cautions that the peak expiratory flow rate measurement is not a perfect indication of asthma severity. Likewise, the spacer devices are not indicated for all patients with asthma who are taking inhaled corticosteroids. Finally, the author emphasizes that anti- inflammatory agents should be effectively used when indicated.
AB - To determine if primary care physicians have been adhering to guidelines set forth by the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report Guidelines for the Diagnosis and Management of Asthma, the author gauged the use of peak flow meters in a hospital family training program. Specifically investigated were the physicians' response to results from the peak flow meters and their prescribing practices regarding the beclomethasone dipropionate metered-dose inhaler. Overall, the use of peak flow meters among the 20 patients included in this study averaged 70%, up from 10% in earlier studies. Similarly, 45% of these patients received prescriptions for beclomethasone metered-dose inhalers with spacer devices. Although these results appear to indicate that physicians are following the aforementioned guidelines, the author cautions that the peak expiratory flow rate measurement is not a perfect indication of asthma severity. Likewise, the spacer devices are not indicated for all patients with asthma who are taking inhaled corticosteroids. Finally, the author emphasizes that anti- inflammatory agents should be effectively used when indicated.
UR - http://www.scopus.com/inward/record.url?scp=0029943222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029943222&partnerID=8YFLogxK
U2 - 10.7556/jaoa.1996.96.5.305
DO - 10.7556/jaoa.1996.96.5.305
M3 - Article
C2 - 8936448
AN - SCOPUS:0029943222
SN - 0098-6151
VL - 96
SP - 305
EP - 308
JO - Journal of the American Osteopathic Association
JF - Journal of the American Osteopathic Association
IS - 5
ER -